long term effects of glp-1 drugs Exploring the Side Receptor Agonist: To Ensure Its Optimal Positioning Your guide to GLP-1 side

In an investigative report in partnership with KFF Health News, NBC News Anne Thompson reports on the growing cases of overdoses involving GLP-1 weight loss drugs.

The GLP1-RAs vs sodium-glucose cotransporter-2 (SGLT-2) inhibitors cohort included new users of GLP-1 RAs (n=83,464) or SGLT-2 inhibitors (n=78,366), and the GLP1-RAs vs dipeptidyl peptidase-4 (DPP-4) inhibitors cohort included new users of GLP-1 RAs (n=108,322) or DPP-4 inhibitors (n=55,411)

The primary outcome was change in HbA1c from baseline

This probiotic formulation includes strains that promote gut health and improve digestion

This unique formula activates GLP-1 and CB2 receptors to help reduce appetite, promote faster and longer-lasting fullness, support healthy glucose metabolism and craving control, and enhance mood and energy levels